Literature DB >> 8685890

Lymphocyte beta2-adrenergic receptors and plasma catecholamine levels in lead-exposed workers.

H R Chang1, S S Chen, T J Chen, C H Ho, H C Chiang, H S Yu.   

Abstract

The effect of lead exposure on beta2-adrenoceptor density and catecholamine response was studied in 26 male workers and 1 female worker, exposed to lead on average for 6 years. The systolic blood pressure in lead workers (101-160 mmHg, 124.4 +/- 14.7 mmHg) was found to be significantly higher than in controls (97-134 mmHg, 115.4 +/- 10.4 mmHg, p < 0.01) as was plasma norepinephrine (0.51 +/- 0.1 microg/liter vs 0.24 +/- 0.05 microg/liter, p < 0.01). The density of lymphocyte beta2-adrenergic receptors (Bmax) in lead-exposed workers was 86% lower than that in controls (0.15 +/- 0.08 vs 1.08 +/- 0.29 fmol/0.1 x 10(6) cells; p < 0.01). The dissociation constants (Kd) of [125I]iodocyanopindolol were 93.6 +/- 42.6 and 87.9 +/- 42.7 pM in lead-exposed workers and controls, respectively. Multiple linear regression analysis showed that elevation of systolic pressure was closely related to (a) blood lead levels, (b) decreased beta2-adrenergic receptor density, and (c) increased plasma catecholamine levels in lead-exposed workers. Linear regression analysis revealed that both plasma norepinephrine levels and beta2-adrenoceptor density (Bmax) were highly correlated with both systolic blood pressures and blood lead levels in lead-exposed workers, and a highly significant negative correlation was found to exist between Bmax and plasma norepinephrine levels (r = -0.82, p < 0.001). These data therefore demonstrate that there is a close relationship between elevated plasma catecholamine levels, decreased beta2-adrenergic receptors, and elevated blood pressure in lead-exposed workers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8685890     DOI: 10.1006/taap.1996.0136

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  8 in total

Review 1.  Occupational and environmental agents as endocrine disruptors: experimental and human evidence.

Authors:  A Baccarelli; A C Pesatori; P A Bertazzi
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

2.  Evaluation of peripheral blood neutrophil leucocytes in lead-exposed workers.

Authors:  Luigi Di Lorenzo; Andrea Silvestroni; Maria Giuliana Martino; Tommaso Gagliardi; Marisa Corfiati; Leonardo Soleo
Journal:  Int Arch Occup Environ Health       Date:  2006-01-17       Impact factor: 3.015

Review 3.  Mechanisms of lead-induced hypertension and cardiovascular disease.

Authors:  Nosratola D Vaziri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

Review 4.  Lead-induced hypertension: role of oxidative stress.

Authors:  Nosratola D Vaziri; Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 5.  The vascular system as a target of metal toxicity.

Authors:  Walter C Prozialeck; Joshua R Edwards; Daniel W Nebert; James M Woods; Aaron Barchowsky; William D Atchison
Journal:  Toxicol Sci       Date:  2007-10-18       Impact factor: 4.849

6.  Comprehensive Electrocardiographic Analysis of Lead Exposed Workers: An Arrhythmic Risk Assessment Study.

Authors:  Ugur N Karakulak; Omer H Yilmaz; Engin Tutkun; Meside Gunduzoz; Emine Ercan Onay
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-06-10       Impact factor: 1.468

Review 7.  Role of environmental toxicants in the development of hypertensive and cardiovascular diseases.

Authors:  Ehsan Habeeb; Saad Aldosari; Shakil A Saghir; Mariam Cheema; Tahani Momenah; Kazim Husain; Yadollah Omidi; Syed A A Rizvi; Muhammad Akram; Rais A Ansari
Journal:  Toxicol Rep       Date:  2022-03-22

8.  Combined Effect of Lead Exposure and Allostatic Load on Cardiovascular Disease Mortality-A Preliminary Study.

Authors:  Emmanuel Obeng-Gyasi; Alesia C Ferguson; Katherine A Stamatakis; Michael A Province
Journal:  Int J Environ Res Public Health       Date:  2021-06-26       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.